AGGRESSIVE FIBROMATOSIS

Clinical trials for AGGRESSIVE FIBROMATOSIS explained in plain language.

Never miss a new study

Get alerted when new AGGRESSIVE FIBROMATOSIS trials appear

Sign up with your email to follow new studies for AGGRESSIVE FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New drug tested for rare tumors in young women

Disease control Recruiting now

This study tests the drug nirogacestat in 50 premenopausal women (ages 18-40) with desmoid tumors, a rare type of non-cancerous growth. The main goal is to see how the drug affects ovarian function and to monitor any side effects. Participants will take the drug and be followed f…

Matched conditions: AGGRESSIVE FIBROMATOSIS

Phase: PHASE4 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control

Last updated May 17, 2026 02:07 UTC

AGGRESSIVE FIBROMATOSIS

Get alerted when new AGGRESSIVE FIBROMATOSIS trials appear

New drug tested for rare tumors in young women